Schizophrenia Treatment Adherence Investigation (STAI)

CompletedOBSERVATIONAL

Enrollment

550

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions

SchizophreniaSchizoaffective Disorder

Interventions

OTHER

Risk status for medication adherence

Examination of risk status for medication adherence in a cohort of Australian patients diagnosed with schizophrenia

All Listed Sponsors

lead

Janssen-Cilag Pty Ltd

INDUSTRY

NCT01001481 - Schizophrenia Treatment Adherence Investigation (STAI) | Biotech Hunter | Biotech Hunter